Bayer AG NA (XETRA:BAYN) — Stock Price
Bayer AG NA (XETRA:BAYN) is currently trading at €49.23 EUR, down 1.16% today. Over the past 52 weeks, shares have ranged between €25.96 and €53.36. This page tracks Bayer AG NA's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Bayer AG NA (BAYN) market capitalisation.
Bayer AG NA (BAYN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bayer AG NA's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bayer AG NA Income Statement — Revenue, Profit & Earnings by Year
Bayer AG NA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €45.58 Billion | €46.61 Billion | €47.64 Billion | €50.74 Billion | €44.08 Billion |
| Cost of Revenue | €18.59 Billion | €21.27 Billion | €19.75 Billion | €19.87 Billion | €16.82 Billion |
| Gross Profit | €26.98 Billion | €25.34 Billion | €27.89 Billion | €30.87 Billion | €27.27 Billion |
| Research & Development | €5.77 Billion | €6.21 Billion | €5.37 Billion | €6.57 Billion | €5.41 Billion |
| SG&A | €2.16 Billion | €2.57 Billion | €2.45 Billion | €2.84 Billion | €2.96 Billion |
| Total Operating Expenses | €20.03 Billion | €20.86 Billion | €19.48 Billion | €22.63 Billion | €19.34 Billion |
| Operating Income | €6.95 Billion | €4.48 Billion | €8.41 Billion | €8.24 Billion | €7.93 Billion |
| EBITDA | €11.01 Billion | €8.53 Billion | €12.34 Billion | €12.19 Billion | €11.67 Billion |
| EBIT | €6.95 Billion | €4.48 Billion | €8.41 Billion | €8.24 Billion | €7.93 Billion |
| Interest Expense | €1.72 Billion | €1.96 Billion | €1.74 Billion | €1.67 Billion | €1.23 Billion |
| Income Before Tax | €-3.13 Billion | €-2.33 Billion | €-1.62 Billion | €4.67 Billion | €2.05 Billion |
| Income Tax Expense | €466.00 Million | €212.00 Million | €1.32 Billion | €504.00 Million | €1.02 Billion |
| Net Income | €-3.62 Billion | €-2.55 Billion | €-2.94 Billion | €4.15 Billion | €1.00 Billion |
Bayer AG NA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bayer AG NA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €110.61 Billion | €110.85 Billion | €116.26 Billion | €124.88 Billion | €120.24 Billion |
| Total Current Assets | €32.45 Billion | €34.44 Billion | €37.56 Billion | €37.76 Billion | €32.58 Billion |
| Cash & Equivalents | €6.67 Billion | €6.19 Billion | €5.91 Billion | €5.17 Billion | €4.56 Billion |
| Short-term Investments | €1.19 Billion | €1.90 Billion | €4.68 Billion | €4.98 Billion | €3.17 Billion |
| Net Receivables | €12.19 Billion | €8.97 Billion | €9.35 Billion | €10.32 Billion | €10.05 Billion |
| Inventory | €12.38 Billion | €13.47 Billion | €13.95 Billion | €13.60 Billion | €11.27 Billion |
| Property, Plant & Equipment | €12.65 Billion | €13.46 Billion | €13.32 Billion | €13.67 Billion | €12.69 Billion |
| Goodwill | €28.06 Billion | €30.02 Billion | €32.30 Billion | €39.65 Billion | €40.11 Billion |
| Total Liabilities | €84.54 Billion | €78.81 Billion | €83.18 Billion | €85.95 Billion | €87.07 Billion |
| Total Current Liabilities | €32.59 Billion | €28.95 Billion | €29.46 Billion | €35.08 Billion | €29.40 Billion |
| Long-term Debt | €30.78 Billion | €34.55 Billion | €37.23 Billion | €32.83 Billion | €35.55 Billion |
| Net Debt | €30.77 Billion | €34.62 Billion | €38.88 Billion | €36.48 Billion | €34.97 Billion |
| Total Stockholder Equity | €25.95 Billion | €31.91 Billion | €32.93 Billion | €38.77 Billion | €33.02 Billion |
| Retained Earnings | €6.73 Billion | €9.87 Billion | €12.18 Billion | €17.23 Billion | €13.35 Billion |
Bayer AG NA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bayer AG NA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €4.57 Billion | €7.37 Billion | €5.12 Billion | €7.09 Billion | €5.09 Billion |
| Capital Expenditures | €2.49 Billion | €2.78 Billion | €2.75 Billion | €2.95 Billion | €2.61 Billion |
| Free Cash Flow | €2.08 Billion | €4.59 Billion | €2.37 Billion | €4.14 Billion | €2.48 Billion |
| Investing Cash Flow | €-1.61 Billion | €164.00 Million | €-4.01 Billion | €-2.38 Billion | €855.00 Million |
| Financing Cash Flow | €-2.19 Billion | €-7.18 Billion | €-679.00 Million | €-4.22 Billion | €-5.64 Billion |
| Dividends Paid | €127.00 Million | €131.00 Million | €2.38 Billion | €1.99 Billion | €1.99 Billion |
| Stock-Based Compensation | — | €58.00 Million | €153.00 Million | €365.00 Million | €238.00 Million |
| Depreciation | €4.05 Billion | €4.05 Billion | €3.93 Billion | €6.50 Billion | €3.06 Billion |
| Change in Cash | €480.00 Million | €284.00 Million | €736.00 Million | €607.00 Million | €373.00 Million |
Bayer AG NA Earnings History — EPS Actual vs. Analyst Estimates
Track Bayer AG NA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Mar 03, 2026 | -3.82 | 0.38 | -1105.26% |
| Nov 11, 2025 | 0.57 | 0.32 | +78.13% |
| Aug 06, 2025 | 1.23 | 0.79 | +55.70% |
| May 13, 2025 | 2.49 | 2.28 | +9.21% |
| Mar 05, 2025 | 1.05 | 0.99 | +5.78% |
| Nov 12, 2024 | 0.24 | 0.32 | -25.00% |
| Aug 06, 2024 | 0.94 | 0.96 | -2.08% |